World Wires · story 20246 · unverified · 1 source(s)

Transgene Will Present a Poster on Preclinical Data from a Novel Oncolytic Virus at SITC 2026

Strasbourg, France, October 5, 2026, 8:00 a.m. CET – Transgene (Euronext Paris: TNG) , a biotech company that designs and develops virus-based immunotherap

Open in the desk

Coverage

• Transgene Will Present a Poster on Preclinical Data from a Novel Oncolytic Virus at SITC 2026 GlobeNewswire: public companies · tier D · clear net · 2026-10-05 06:00 UTC
• Transgene présentera un poster sur les données précliniques de son virus oncolytique innovant au SITC 2026 GlobeNewswire: public companies · tier D · clear net · 2026-10-05 06:00 UTC

What this site indexes